Table 1 Clinical profiles of patients with AESD and PFS.
Characteristic | AESD (n = 20) | PFS (n = 41) | p value | |
---|---|---|---|---|
Female: male | 8:12 | 22:19 | 0.23 | |
Mean (SD) age at onset, months | 23.60 (14.23) | 34.20 (25.37) | 0.04a | |
Mean (SD) interval from symptom onset to EEG, h | 21.95 (14.47) | 13.39 (9.08) | 0.02a | |
Seizure treatment | Yes | 9 | 22 | 0.65 |
No | 11 | 19 | ||
Seizure medication(s) provided | MDL | 6 | 11 | 0.43 |
DZP | 1 | 9 | ||
fPHT | 2 | 0 | ||
PB | 1 | 1 | ||
Vitamin | 0 | 1 | ||
Outcome | No sequelae | 5 | 41 | < 0.01b |
Mild-to-moderate sequelae | 10 | 0 | ||
Severe sequelae | 5 | 0 |